Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 294,448 | 9,682 | 9,216 | 17,071 | 6,966 |
| Cost of Goods | 577 | 1,327 | 553 | 569 | 551 |
| Gross Profit | 293,871 | 8,355 | 8,663 | 16,502 | 6,415 |
| Operating Expenses | 69,772 | 27,227 | 26,685 | 29,439 | 29,893 |
| Operating Income | 224,676 | -18,545 | -17,469 | -12,368 | -22,927 |
| Interest Expense | 5,204 | 5,164 | 5,117 | 5,225 | 5,252 |
| Other Income | 600 | 691 | 789 | 810 | 783 |
| Pre-tax Income | 220,072 | -23,018 | -21,797 | -16,783 | -27,396 |
| Income Tax | -6,014 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 226,086 | -23,018 | -21,797 | -16,783 | -27,396 |
| Net Income | $226,086 | $-23,018 | $-21,797 | $-16,783 | $-27,396 |
| EPS Basic Total Ops | 2.13 | -0.22 | -0.21 | -0.15 | -0.26 |
| EPS Basic Continuous Ops | 2.13 | -0.22 | -0.21 | -0.16 | -0.26 |
| EPS Diluted Total Ops | 1.95 | -0.22 | -0.21 | -0.15 | -0.26 |
| EPS Diluted Continuous Ops | 1.94 | -0.22 | -0.21 | -0.16 | -0.26 |
| EBITDA(a) | $254,601 | $-17,273 | $-16,222 | $-11,077 | $-21,644 |